Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
110.55
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
22
Open
110.55
Bid (Size)
110.00 (200)
Ask (Size)
112.90 (100)
Prev. Close
110.55
Today's Range
110.55 - 110.55
52wk Range
105.27 - 139.15
Shares Outstanding
1,750,942,289
Dividend Yield
2.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
March 09, 2026
As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Profitable Stocks on Our Watchlist and 1 We Avoid
March 09, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via
StockStory
Performance
YTD
-11.0%
-11.0%
1 Month
-0.5%
-0.5%
3 Month
-8.8%
-8.8%
6 Month
-16.2%
-16.2%
1 Year
-19.5%
-19.5%
More News
Read More
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
March 04, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Abbott Laboratories (NYSE:ABT) Emerges as a Top Dividend Stock with Strong Fundamentals
↗
March 02, 2026
Via
Chartmill
2 Reasons to Like ABT and 1 to Stay Skeptical
March 01, 2026
Via
StockStory
Topics
Stocks
Supply Chain
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
↗
February 25, 2026
Via
The Motley Fool
Topics
Cannabis
Initial Public Offering
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off
February 24, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Initial Public Offering
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich
↗
February 23, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
February 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
February 19, 2026
Via
MarketMinute
Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector
February 19, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
3 Large-Cap Stocks with Solid Fundamentals
February 18, 2026
Via
StockStory
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
February 18, 2026
Via
MarketMinute
Topics
Earnings
Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum
February 17, 2026
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down
February 15, 2026
Via
StockStory
1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky
February 12, 2026
Via
StockStory
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever
↗
February 12, 2026
Via
The Motley Fool
1 Reason I'm Never Selling AbbVie Stock
↗
February 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
February 09, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
February 09, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Product Recall
The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
↗
February 05, 2026
Via
MarketBeat
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
February 05, 2026
Via
Finterra
Topics
Product Recall
World Trade
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
↗
February 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
February 03, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Frequently Asked Questions
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 110.55
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 03/10/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 193.57B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 194B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.